Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.UK court uphelds two KCI patents validity
The Court also found that NPWT products marketed by Smith & Nephew (SNN) infringe one of the patents. In June 2010, the High Court of Justice Chancery Division,
The Court also found that NPWT products marketed by Smith & Nephew (SNN) infringe one of the patents. In June 2010, the High Court of Justice Chancery Division,
Naurex said that Numerous studies have shown that ketamine has a markedly faster onset of action than other antidepressants (within hours, instead of weeks) and alleviates depression symptoms
Merck said that the DEFINE trial was an 18-month study in more than 1,600 patients with or at high risk for CHD who were already receiving statins and
In the current trial, the patients received four standardised doses of ToleroMune T-cell vaccine over a number of weeks. During the study, investigators administered a challenge dose of
The trial demonstrate the potent and consistent antiviral efficacy of TMC435 in patients who had failed earlier treatment with peg-IFN and ribavarin (standard of care), as well as
These generic Clarinex tablets contain desloratidine 5mg. Sun Pharma said that Clarinex is a prescription medication, treats year-round allergy symptoms and ongoing hives of unknown cause, in adults
The Phase III trial is designed to evaluate the therapeutic effects of Cladribine tablets on the time to conversion to multiple sclerosis (MS) in people with a first
Sun Pharma said that these generic Tiazac capsules contain Diltiazem Hydrochloride extended-release USP, 120mg, 180mg, 240mg,300mg and 360mg, and are therapeutically equivalent to Biovail’s Tiazac extended release capsules.
Bioniche said that the current milestone payment was triggered by Urocidin attaining a contractual efficacy goal from an ongoing US Food and Drug Administration (FDA) Phase III registration
Bromday (formerly referred to as XiDay), an once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract